Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Delaidelli

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Cancer Immunology Research|August 1, 2025
Endoglin-directed CAR-T cells Comprehensively Target Tumors in Advanced SarcomasHarrison R Berger, Malina Maharana, Jeneffer Mirabal, et al.
EMBO Reports|November 1, 2019
Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasisAmal M El-Naggar, Syam Prakash Somasekharan, Yemin Wang, et al.
Science Advances|August 23, 2023
A MYCN-independent mechanism mediating secretome reprogramming and metastasis in <i>MYCN</i>-amplified neuroblastomaHai-Feng Zhang, Alberto Delaidelli, Sumreen Javed, et al.
EMBO Reports|May 29, 2025
Author Correction: Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasisAmal M El-Naggar, Syam Prakash Somasekharan, Yemin Wang, et al.
Genome Medicine|September 7, 2023
Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumoursArash Nabbi, Pengbo Beck, Alberto Delaidelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2023
Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing SarcomaBrian Mooney, Gian Luca Negri, Taras Shyp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 19, 2019
CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain TumorsRobbie G Majzner, Johanna L Theruvath, Anandani Nellan, et al.
Nature Medicine|April 29, 2020
Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumorsJohanna Theruvath, Elena Sotillo, Christopher W Mount, et al.
Cancer Discovery|May 22, 2021
Proteomic Screens for Suppressors of Anoikis Identify IL1RAP as a Promising Surface Target in Ewing SarcomaHai-Feng Zhang, Christopher S Hughes, Wei Li, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastomaAmber K Weiner, Alexander B Radaoui, Matthew Tsang, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Cancer Immunology Research|August 1, 2025
Endoglin-directed CAR-T cells Comprehensively Target Tumors in Advanced SarcomasHarrison R Berger, Malina Maharana, Jeneffer Mirabal, et al.
EMBO Reports|November 1, 2019
Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasisAmal M El-Naggar, Syam Prakash Somasekharan, Yemin Wang, et al.
Science Advances|August 23, 2023
A MYCN-independent mechanism mediating secretome reprogramming and metastasis in <i>MYCN</i>-amplified neuroblastomaHai-Feng Zhang, Alberto Delaidelli, Sumreen Javed, et al.
EMBO Reports|May 29, 2025
Author Correction: Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasisAmal M El-Naggar, Syam Prakash Somasekharan, Yemin Wang, et al.
Genome Medicine|September 7, 2023
Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumoursArash Nabbi, Pengbo Beck, Alberto Delaidelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2023
Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing SarcomaBrian Mooney, Gian Luca Negri, Taras Shyp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 19, 2019
CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain TumorsRobbie G Majzner, Johanna L Theruvath, Anandani Nellan, et al.
Nature Medicine|April 29, 2020
Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumorsJohanna Theruvath, Elena Sotillo, Christopher W Mount, et al.
Cancer Discovery|May 22, 2021
Proteomic Screens for Suppressors of Anoikis Identify IL1RAP as a Promising Surface Target in Ewing SarcomaHai-Feng Zhang, Christopher S Hughes, Wei Li, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastomaAmber K Weiner, Alexander B Radaoui, Matthew Tsang, et al.
Pageof 6